Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
Philip J. Saylor(Massachusetts General Hospital), David T. Miyamoto(Broad Institute), René Balza(Harvard University), Haley M. Pleskow(Harvard University), Erika Meneely(Harvard University), Alarice Lowe(Brigham and Women's Hospital), Jacob Ukleja(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Richard J. Lee(La Roche College), Kara Olivier(Harvard University), Erika Kusaka(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), Rebecca Fisher(Harvard University), Mehmet Toner(Center for Cancer Research), Yukako Otani(Harvard University), Priscilla Oluwakemi Badusi(Harvard University), Matthew R. Smith(Harvard University), Beow Y. Yeap(Harvard University), Keisuke Otani(Harvard University)
Cited by 7
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k